Jacob J. Sims serves as Senior Vice President, Chief Technology Officer of the Company. Mr. Sims has served as our Senior Vice President, Chief Technology Officer, since April 2018, and is responsible for all aspects of our information technology and security, including IT infrastructure, development and execution of our technology strategy and roadmap, evolution of data science and advanced analytics, development of new product and capabilities, service platforms, and IT security. Mr. Sims has significant experience leading large-scale healthcare IT organizations and specializes in transformative initiatives and data-centric product cultivation. Prior to joining HMS, Mr. Sims served as Chief Technology Officer and Interim Head of Product for WebMD Health Services, a provider of health information services, from July 2016 to April 2018. From July 2014 to July 2016, Mr. Sims served as Vice President of Development and Technology of Premise Health, a direct healthcare access provider, and from April 2013 to July 2014, he served as Vice President of Development and Technology for CHS Onsite, a provider of medical management services. Prior to CHS Onsite, Mr. Sims held leadership positions at Xerox, Inc. and CredenceHealth, Inc.
Jacob Sims is 39, he's been the Senior Vice President and Chief Technology Officer of HMS Corp since 2018. There are 16 older and no younger executives at HMS Corp. The oldest executive at HMS Holdings Corp is Richard Stowe, 76, who is the Independent Director.
Jacob's mailing address filed with the SEC is 5615 HIGH POINT DRIVE, , IRVING, TX, 75038.
Over the last 22 years, insiders at HMS Corp have traded over $52,929,119 worth of HMS Corp stock and bought 86,410 units worth $1,190,400 . The most active insiders traders include William C Lucia, Daniel Newman Mendelson, and Iii William F Miller. On average, HMS Corp executives and independent directors trade stock every 20 days with the average trade being worth of $938,779. The most recent stock trade was executed by Richard H Stowe on 19 October 2020, trading 3,530 units of HMSY stock currently worth $75,401.
HMS advances healthcare by helping organizations reduce costs and improve health outcomes. Through its industry-leading technology, analytics and engagement solutions, HMS saves billions of dollars annually while helping consumers lead healthier lives. HMS provides a broad range of payment accuracy and population health management solutions that help move the healthcare system forward.
HMS Corp executives and other stock owners filed with the SEC include: